Drug Profile
Cycloserine/lurasidone - NRx Pharmaceuticals
Alternative Names: Cyclurad; D-cycloserine/lurasidone.; Lurasidone/cycloserine; NRX-101Latest Information Update: 22 Apr 2024
Price :
$50
*
At a glance
- Originator NeuroRX
- Developer NeuroRX; NRx Pharmaceuticals
- Class Analgesics; Anti-infectives; Antidepressants; Antituberculars; Anxiolytics; Behavioural disorder therapies; Isoindoles; Isoxazoles; Piperazines; Small molecules; Thiazoles
- Mechanism of Action Cell wall inhibitors; Dopamine D2 receptor antagonists; Glycine gated NMDA receptor agonists; Serotonin 2A receptor antagonists; Serotonin 2C receptor antagonists; Serotonin 7 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Urinary tract infections
Highest Development Phases
- Phase III Bipolar depression
- Phase II/III Suicidal ideation
- Phase II Pain
- Preclinical Post-traumatic stress disorders; Urinary tract infections